John Oldenhof's Linkedin Analytics

Experienced leader in Early Phase Clinical Research; overseeing clinical pharmacology, pharmacokinetics, biostatistics, data management and medical writing groups. Provided scientific guidance on hundreds of Phase I studies and dozens of first-in-human studies. Extensive experience in early phase development of CNS drugs, including antiepileptic drugs. Almost two decades of experience in the design and analysis of human abuse potential studies. Parent of a child with a rare genetic epilepsy caused by a de novo STXBP1 gene variant. Using my academic and industry experience to support the STXBP1 Foundation in order to identify and advance treatments for rare genetic epilepsies.